CYN vs LIDR vs RBOT vs IROQ vs ZVIA

For growth investors, AEye, Inc.

(LIDR) is the stronger pick with 15. 3% revenue growth year-over-year, versus -40. 5% for Cyngn Inc. (CYN). IF Bancorp, Inc. (IROQ) offers the better valuation at 19. 4x trailing P/E, making it the more compelling value choice. Analysts rate Zevia PBC (ZVIA) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, IF Bancorp, Inc.

(IROQ) delivered a total return of +25. 4%, compared to -100. 0% for Cyngn Inc. (CYN). Over 10 years, the gap is even starker: IROQ returned +60. 1% versus CYN's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), IF Bancorp, Inc.

(IROQ) is the lower-risk stock at -0. 05β versus AEye, Inc. 's 2. 51β — meaning LIDR is approximately -4752% more volatile than IROQ relative to the S&P 500. On balance sheet safety, AEye, Inc. (LIDR) carries a lower debt/equity ratio of 0% versus 89% for IF Bancorp, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), AEye, Inc.

(LIDR) is pulling ahead at 15. 3% versus -40. 5% for Cyngn Inc. (CYN). On earnings-per-share growth, the picture is similar: IF Bancorp, Inc. grew EPS 140. 4% year-over-year, compared to 21. 2% for Vicarious Surgical Inc.. Over a 3-year CAGR, ZVIA leads at -0. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

IF Bancorp, Inc.

(IROQ) is the more profitable company, earning 8. 9% net margin versus -145. 7% for AEye, Inc. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IROQ leads at 12. 2% versus -136. 2% for LIDR. At the gross margin level — before operating expenses — IROQ leads at 54. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, IROQ (1.

5% yield) pays a dividend. CYN, LIDR, RBOT, ZVIA do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, IF Bancorp, Inc.

(IROQ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 05), 1. 5% yield). Cyngn Inc. (CYN) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IROQ: +60. 1%, CYN: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CYN (Technology) and LIDR (Consumer Cyclical) and RBOT (Healthcare) and IROQ (Financial Services) and ZVIA (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CYN is a small-cap quality compounder stock; LIDR is a small-cap high-growth stock; RBOT is a small-cap quality compounder stock; IROQ is a small-cap quality compounder stock; ZVIA is a small-cap quality compounder stock. IROQ pays a dividend while CYN, LIDR, RBOT, ZVIA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.